194 related articles for article (PubMed ID: 8930366)
1. Glycoxidation and oxidative stress in Parkinson disease and diffuse Lewy body disease.
Castellani R; Smith MA; Richey PL; Perry G
Brain Res; 1996 Oct; 737(1-2):195-200. PubMed ID: 8930366
[TBL] [Abstract][Full Text] [Related]
2. Advanced glycation modification of Rosenthal fibers in patients with Alexander disease.
Castellani RJ; Perry G; Harris PL; Monnier VM; Cohen ML; Smith MA
Neurosci Lett; 1997 Aug; 231(2):79-82. PubMed ID: 9291145
[TBL] [Abstract][Full Text] [Related]
3. Review of pentosidine and pyrraline in food and chemical models: formation, potential risks and determination.
Li H; Yu SJ
J Sci Food Agric; 2018 Jul; 98(9):3225-3233. PubMed ID: 29280151
[TBL] [Abstract][Full Text] [Related]
4. Evidence of oxidative stress in the neocortex in incidental Lewy body disease.
Dalfó E; Portero-Otín M; Ayala V; Martínez A; Pamplona R; Ferrer I
J Neuropathol Exp Neurol; 2005 Sep; 64(9):816-30. PubMed ID: 16141792
[TBL] [Abstract][Full Text] [Related]
5. Hydroxynonenal adducts indicate a role for lipid peroxidation in neocortical and brainstem Lewy bodies in humans.
Castellani RJ; Perry G; Siedlak SL; Nunomura A; Shimohama S; Zhang J; Montine T; Sayre LM; Smith MA
Neurosci Lett; 2002 Feb; 319(1):25-8. PubMed ID: 11814645
[TBL] [Abstract][Full Text] [Related]
6. Advanced glycation end products in human penis: elevation in diabetic tissue, site of deposition, and possible effect through iNOS or eNOS.
Seftel AD; Vaziri ND; Ni Z; Razmjouei K; Fogarty J; Hampel N; Polak J; Wang RZ; Ferguson K; Block C; Haas C
Urology; 1997 Dec; 50(6):1016-26. PubMed ID: 9426743
[TBL] [Abstract][Full Text] [Related]
7. High levels of urinary pentosidine, an advanced glycation end product, in children with acute exacerbation of atopic dermatitis: relationship with oxidative stress.
Tsukahara H; Shibata R; Ohta N; Sato S; Hiraoka M; Ito S; Noiri E; Mayumi M
Metabolism; 2003 Dec; 52(12):1601-5. PubMed ID: 14669163
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy.
Horie K; Miyata T; Maeda K; Miyata S; Sugiyama S; Sakai H; van Ypersole de Strihou C; Monnier VM; Witztum JL; Kurokawa K
J Clin Invest; 1997 Dec; 100(12):2995-3004. PubMed ID: 9399945
[TBL] [Abstract][Full Text] [Related]
9. Neural heme oxygenase-1 expression in idiopathic Parkinson's disease.
Schipper HM; Liberman A; Stopa EG
Exp Neurol; 1998 Mar; 150(1):60-8. PubMed ID: 9514830
[TBL] [Abstract][Full Text] [Related]
10. Formation of advanced glycosylation end products and oxidative stress in young patients with type 1 diabetes.
Tsukahara H; Sekine K; Uchiyama M; Kawakami H; Hata I; Todoroki Y; Hiraoka M; Kaji M; Yorifuji T; Momoi T; Yoshihara K; Beppu M; Mayumi M
Pediatr Res; 2003 Sep; 54(3):419-24. PubMed ID: 12761359
[TBL] [Abstract][Full Text] [Related]
11. Advanced Maillard reaction end products are associated with Alzheimer disease pathology.
Smith MA; Taneda S; Richey PL; Miyata S; Yan SD; Stern D; Sayre LM; Monnier VM; Perry G
Proc Natl Acad Sci U S A; 1994 Jun; 91(12):5710-4. PubMed ID: 8202552
[TBL] [Abstract][Full Text] [Related]
12. Localization of identified advanced glycation end-product structures, N epsilon(carboxymethyl)lysine and pentosidine, in age-related inclusions in human brains.
Kimura T; Takamatsu J; Miyata T; Miyakawa T; Horiuchi S
Pathol Int; 1998 Aug; 48(8):575-9. PubMed ID: 9736403
[TBL] [Abstract][Full Text] [Related]
13. Advanced glycation end products in neurodegeneration: more than early markers of oxidative stress?
Münch G; Gerlach M; Sian J; Wong A; Riederer P
Ann Neurol; 1998 Sep; 44(3 Suppl 1):S85-8. PubMed ID: 9749578
[TBL] [Abstract][Full Text] [Related]
14. Glycation, glycoxidation, and cross-linking of collagen by glucose. Kinetics, mechanisms, and inhibition of late stages of the Maillard reaction.
Fu MX; Wells-Knecht KJ; Blackledge JA; Lyons TJ; Thorpe SR; Baynes JW
Diabetes; 1994 May; 43(5):676-83. PubMed ID: 8168645
[TBL] [Abstract][Full Text] [Related]
15. New biomarkers of Maillard reaction damage to proteins.
Wells-Knecht KJ; Brinkmann E; Wells-Knecht MC; Litchfield JE; Ahmed MU; Reddy S; Zyzak DV; Thorpe SR; Baynes JW
Nephrol Dial Transplant; 1996; 11 Suppl 5():41-7. PubMed ID: 9044306
[TBL] [Abstract][Full Text] [Related]
16. Levodopa-nonresponsive Lewy body parkinsonism: clinicopathologic study of two cases.
Mark MH; Sage JI; Dickson DW; Schwarz KO; Duvoisin RC
Neurology; 1992 Jul; 42(7):1323-7. PubMed ID: 1620341
[TBL] [Abstract][Full Text] [Related]
17. Generation of protein carbonyls by glycoxidation and lipoxidation reactions with autoxidation products of ascorbic acid and polyunsaturated fatty acids.
Miyata T; Inagi R; Asahi K; Yamada Y; Horie K; Sakai H; Uchida K; Kurokawa K
FEBS Lett; 1998 Oct; 437(1-2):24-8. PubMed ID: 9804165
[TBL] [Abstract][Full Text] [Related]
18. Structure of advanced Maillard reaction products and their pathological role.
Monnier VM; Nagaraj RH; Portero-Otin M; Glomb M; Elgawish AH; Sell DR; Friedlander MA
Nephrol Dial Transplant; 1996; 11 Suppl 5():20-6. PubMed ID: 9044302
[TBL] [Abstract][Full Text] [Related]
19. Tomato paste fraction inhibiting the formation of advanced glycation end-products.
Kiho T; Usui S; Hirano K; Aizawa K; Inakuma T
Biosci Biotechnol Biochem; 2004 Jan; 68(1):200-5. PubMed ID: 14745184
[TBL] [Abstract][Full Text] [Related]
20. Evidence for oxidative stress in Pick disease and corticobasal degeneration.
Castellani R; Smith MA; Richey PL; Kalaria R; Gambetti P; Perry G
Brain Res; 1995 Oct; 696(1-2):268-71. PubMed ID: 8574681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
